Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Nov 13;165(10):1339-41.

Intention-to-treat principle

V M Montori  1 , G H Guyatt
Affiliations
Review

Intention-to-treat principle

V M Montori et al. CMAJ. .
No abstract available

PubMed Disclaimer

Figures

None
Fig. 1: Per protocol analysis introduces bias into the estimate of intervention efficacy. For our analysis of this hypothetical randomized controlled trial of patients with cerebrovascular disease, it is assumed that the surgery is ineffective in preventing the adverse outcome of interest (stroke). Per protocol analysis of the treatment group (surgery + acetylsalicylic acid [ASA]) includes only those patients who adhered to the protocol (in this case, those who received surgery); “nonadherent” patients (those who died before having the opportunity to undergo surgery) are excluded. With this analysis, the event rate is 0.11 in the surgery + ASA arm and 0.20 in the control arm, which represents a relative risk reduction (RRR) of 0.45. The intention-to-treat analysis, which counts all events in all randomized patients, shows equal event rates (0.20) in both arms and no risk reduction. This analysis suggests the underlying truth, a treatment effect of zero. R = randomization.
See this image and copyright information in PMC

References

    1. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med 1980;303:1038-41. - PubMed
    1. Horwitz R, Viscoli C, Berkman L. Treatment adherence and risk of death after myocardial infarction. Lancet 1990;336:542-5. - PubMed
    1. Altman D. Clinical trials. In: Practical statistics for medical research. London: Chapman & Hall; 1991. p. 440-4761.
    1. Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53. - PubMed
    1. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319:670-47. - PMC - PubMed

Publication types